Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFM) Invested Capital: 2010-2025

Historic Invested Capital for Sunshine Biopharma (SBFM) over the last 14 years, with Sep 2025 value amounting to $24.2 million.

  • Sunshine Biopharma's Invested Capital fell 3.35% to $24.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.2 million, marking a year-over-year decrease of 3.35%. This contributed to the annual value of $23.5 million for FY2024, which is 10.81% up from last year.
  • Latest data reveals that Sunshine Biopharma reported Invested Capital of $24.2 million as of Q3 2025, which was down 5.78% from $25.7 million recorded in Q2 2025.
  • In the past 5 years, Sunshine Biopharma's Invested Capital registered a high of $41.9 million during Q2 2022, and its lowest value of -$1.2 million during Q3 2021.
  • For the 3-year period, Sunshine Biopharma's Invested Capital averaged around $23.2 million, with its median value being $23.5 million (2024).
  • Per our database at Business Quant, Sunshine Biopharma's Invested Capital soared by 10,117.97% in 2022 and then plummeted by 45.61% in 2023.
  • MRQ analysis of 5 years shows Sunshine Biopharma's Invested Capital stood at $211,662 in 2021, then skyrocketed by 10,117.97% to $21.6 million in 2022, then fell by 1.94% to $21.2 million in 2023, then rose by 10.81% to $23.5 million in 2024, then increased by 2.97% to $24.2 million in 2025.
  • Its Invested Capital stands at $24.2 million for Q3 2025, versus $25.7 million for Q2 2025 and $22.7 million for Q1 2025.